JP2527896B2 - ヒト骨由来インスリン様成長因子結合タンパク - Google Patents

ヒト骨由来インスリン様成長因子結合タンパク

Info

Publication number
JP2527896B2
JP2527896B2 JP4510060A JP51006092A JP2527896B2 JP 2527896 B2 JP2527896 B2 JP 2527896B2 JP 4510060 A JP4510060 A JP 4510060A JP 51006092 A JP51006092 A JP 51006092A JP 2527896 B2 JP2527896 B2 JP 2527896B2
Authority
JP
Japan
Prior art keywords
igfbp
hbd
igf
bone
purified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP4510060A
Other languages
English (en)
Japanese (ja)
Other versions
JPH06501270A (ja
Inventor
モハン，サブラマン
ベイリンク，デイビッド・ジェイ
Original Assignee
ベーリンガー・マンハイム・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ベーリンガー・マンハイム・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング filed Critical ベーリンガー・マンハイム・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング
Publication of JPH06501270A publication Critical patent/JPH06501270A/ja
Application granted granted Critical
Publication of JP2527896B2 publication Critical patent/JP2527896B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
JP4510060A 1991-04-19 1992-04-15 ヒト骨由来インスリン様成長因子結合タンパク Expired - Lifetime JP2527896B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68835391A 1991-04-19 1991-04-19
US688,353 1991-04-19
PCT/US1992/003122 WO1992018154A1 (fr) 1991-04-19 1992-04-15 Proteine de liaison de facteurs de croissance analogues a l'insuline derivee d'os humain

Publications (2)

Publication Number Publication Date
JPH06501270A JPH06501270A (ja) 1994-02-10
JP2527896B2 true JP2527896B2 (ja) 1996-08-28

Family

ID=24764088

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4510060A Expired - Lifetime JP2527896B2 (ja) 1991-04-19 1992-04-15 ヒト骨由来インスリン様成長因子結合タンパク

Country Status (11)

Country Link
EP (1) EP0580752A4 (fr)
JP (1) JP2527896B2 (fr)
KR (1) KR0129864B1 (fr)
AU (1) AU658187B2 (fr)
CA (1) CA2107475A1 (fr)
CZ (1) CZ283601B6 (fr)
FI (1) FI934588A0 (fr)
HU (1) HUT70297A (fr)
NO (1) NO933742L (fr)
RU (1) RU2114120C1 (fr)
WO (1) WO1992018154A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69233155T2 (de) 1991-01-08 2004-06-03 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Insulinartigen wachstumsfaktor bindendes protein
US5643867A (en) * 1992-08-26 1997-07-01 Celtrix Pharmaceuticals, Inc. Method for treating catabolic conditions
US5407913A (en) * 1992-12-03 1995-04-18 Celtrix Pharmaceuticals, Inc. Method and composition for systemic treatment of tissue injury
US6124259A (en) * 1993-01-28 2000-09-26 Celtrix Pharmaceuticals, Inc. Method for treating ophthalmic disorders with IGFBP
EP0800530A4 (fr) * 1994-07-20 1998-12-02 Celtrix Pharma Complexe igf/igfbp destines a favoriser la formation osseuse et a reguler le remodelage osseux
ES2293137T3 (es) 1995-10-11 2008-03-16 Novartis Vaccines And Diagnostics, Inc. Combinacion de pdgf, kgf,igf e igfbp para curacion de heridas.
HUP0302525A2 (hu) 2001-01-05 2003-10-28 Abgenix, Inc. Az inzulinszerű növekedési faktor I receptor elleni ellenanyagok
US20190018025A1 (en) * 2015-12-31 2019-01-17 Siemens Healthcare Diagnostics Inc. Non-recombinant human insulin-like growth factor binding protein concentrate
US10212614B2 (en) * 2015-12-31 2019-02-19 Facebook, Inc. Igniting network nodes in a multi-hop wireless network

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7907958A (nl) * 1979-10-30 1981-06-01 Wijn Adriaan Jacques De Kar of onderstel voorzien van opklapbare wielen.
IL68218A (en) * 1983-03-23 1985-12-31 Univ Ramot Compositions for cartilage repair comprising embryonal chondrocytes
ATE112684T1 (de) * 1987-04-28 1994-10-15 Boehringer Mannheim Gmbh Verwendung von igf-ii zur behandlung von knochenkrankheiten.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Ｂｉｏｃｈｅｍ，Ｂｉｏｐｈｙｓ．Ｒｅｓ．Ｃｏｍｍｕｎ．ｖｏｌ，１７６Ｎｏ．１（１９９１）ｐ．２１３−２１８

Also Published As

Publication number Publication date
NO933742L (no) 1993-10-18
CA2107475A1 (fr) 1992-10-20
JPH06501270A (ja) 1994-02-10
WO1992018154A1 (fr) 1992-10-29
AU1784492A (en) 1992-11-17
FI934588A (fi) 1993-10-18
KR0129864B1 (en) 1998-04-09
AU658187B2 (en) 1995-04-06
CZ219093A3 (en) 1994-12-15
EP0580752A4 (en) 1994-08-24
CZ283601B6 (cs) 1998-05-13
FI934588A0 (fi) 1993-10-18
HU9302942D0 (en) 1994-01-28
HUT70297A (en) 1995-09-28
EP0580752A1 (fr) 1994-02-02
RU2114120C1 (ru) 1998-06-27

Similar Documents

Publication Publication Date Title
US5736511A (en) Methods for treatment using acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
Luetteke et al. Characterization of high molecular weight transforming growth factor. alpha. produced by rat hepatocellular carcinoma cells
JP3178714B2 (ja) インスリン様成長因子（ｉｇｆ）結合蛋白複合体の酸不安定サブユニット（ａｌｓ）
EP0546110B1 (fr) Nouvelle proteine de liaison de facteur de croissance analogue a l'insuline igfbp-5
NZ231333A (en) Insulin-like growth factor-binding protein and pharmaceutical compositions containing it
IL85983A (en) Human somatomedin carrier protein subunits, antibodies against them, pharmaceutical compostitions containing them and their use in the preparation of medicaments
JP2527896B2 (ja) ヒト骨由来インスリン様成長因子結合タンパク
US5474766A (en) Methods and compositions for inhibition of hepatic clearance of tissue-type plasminogen activator
WO1992003470A1 (fr) Matiere genetique codant la ifgbp-5
Mazerbourg et al. Insulin-like growth factor binding protein-4 proteolytic degradation in ovine preovulatory follicles: studies of underlying mechanisms
WO1994014471A9 (fr) Procedes et compositions d'inhibition de la clairance hepatique de l'activateur plasminogene de type tissulaire
EP0832221A1 (fr) Facteur de stimulation osseuse
JP2004008027A (ja) ｃＡＭＰの産生活性を有する新規ペプチド
WO1999049894A1 (fr) Antagonistes du gene 6 specifique de l'arret de croissance, et leur utilisation contre des troubles insulinoresistants
AU2004253842A1 (en) An endogenous peptide and active subfragments thereof
US7125961B2 (en) Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
AU638935B2 (en) Acid-labile subunit (als) of insulin-like-growth factor (igf)binding protein complex
US5693754A (en) Inhibitory binding protein for insulin-like growth factors
US20030027753A1 (en) Bone stimulating factor
AU6659800A (en) Bone stimulating factor